|
US4013682A
(en)
*
|
1973-08-03 |
1977-03-22 |
Akzona Incorporated |
N-hydroxy-amidine compounds
|
|
US4101675A
(en)
*
|
1973-11-09 |
1978-07-18 |
Akzona Incorporated |
Novel 2,6-di-substituted phenyl-aminoquanidine containing compositions and methods of using same and pharmaceutical compositions containing the same and therapeutic method
|
|
NL7315350A
(nl)
*
|
1973-11-09 |
1975-05-13 |
Akzo Nv |
Nieuwe aminoguanidine verbindingen.
|
|
NL7407469A
(nl)
*
|
1974-06-01 |
1975-12-03 |
Akzo Nv |
Nieuwe amidinohydrazonverbindingen.
|
|
US5385946A
(en)
*
|
1986-07-10 |
1995-01-31 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Method for treating hypertension with disubstituted granidine compounds
|
|
US5312840A
(en)
*
|
1986-07-10 |
1994-05-17 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
AU655176B2
(en)
|
1990-03-02 |
1994-12-08 |
State of Oregon, acting by and through The Oregon Board of Higher Education acting for and on behalf of The Oregon Health Sciences University, Portland, Oregon, and The University of Oregon, Eugene, Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
US5336689A
(en)
*
|
1990-03-02 |
1994-08-09 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
US5262568A
(en)
*
|
1990-03-02 |
1993-11-16 |
State Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
|
EP0532642A1
(en)
*
|
1990-05-25 |
1993-03-24 |
STATE OF OREGON, acting through OREGON STATE BOARD OF HIGHER EDUCATION, acting for OREGON HEALTH SC. UNIV. AND UNIV. OF OREGON |
Substituted guanidines having high binding to the sigma receptor and the use thereof
|
|
US5847006A
(en)
*
|
1991-02-08 |
1998-12-08 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
EP0940139B1
(en)
*
|
1991-02-08 |
2005-02-02 |
Scion Pharmaceuticals, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
US5741661A
(en)
*
|
1991-02-08 |
1998-04-21 |
Cambridge Neuroscience, Inc. |
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
|
|
ATE245977T1
(de)
*
|
1993-05-27 |
2003-08-15 |
Cenes Ltd |
Therapeutische substituierte guanidine
|
|
EP0739200A4
(en)
*
|
1993-11-23 |
1997-12-17 |
Cambridge Neuroscience Inc |
SUBSTITUTED GUANIDINES FOR THERAPEUTIC USE
|
|
HU225986B1
(en)
*
|
1994-01-10 |
2008-02-28 |
Teva Pharma |
Use of 1-aminoindan derivatives for preparing pharmaceutical compns. and 1-aminoindan derivatives
|
|
US5877218A
(en)
|
1994-01-10 |
1999-03-02 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
US6787569B1
(en)
|
1994-02-03 |
2004-09-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
WO1995020950A1
(en)
*
|
1994-02-03 |
1995-08-10 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US7351743B1
(en)
|
1994-02-03 |
2008-04-01 |
Wyeth |
Therapeutic guanidines
|
|
US6143791A
(en)
*
|
1994-02-03 |
2000-11-07 |
Cambridge Neuroscience, Inc. |
Therapeutic guanidines
|
|
US6025355A
(en)
*
|
1997-05-19 |
2000-02-15 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
US6242198B1
(en)
|
1996-07-25 |
2001-06-05 |
Cambridge Neuroscience, Inc. |
Methods of treatment of eye trauma and disorders
|
|
US6756389B2
(en)
*
|
1996-08-09 |
2004-06-29 |
Cambridge Neuroscience, Inc. |
Pharmaceutically active compounds and methods of use
|
|
ATE292619T1
(de)
|
1996-12-18 |
2005-04-15 |
Teva Pharma |
Aminoindanderivate
|
|
US6737547B1
(en)
|
1998-12-31 |
2004-05-18 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using N-acyl-1H-aminoindenes
|
|
US20040010038A1
(en)
*
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
|
US20070135518A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Marta Weinstock-Rosin |
Use of low-dose ladostigil for neuroprotection
|
|
ES2632638T3
(es)
*
|
2005-12-09 |
2017-09-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Ladostigilo de baja dosis para el tratamiento de la deficiencia cognitiva
|
|
TW200744576A
(en)
*
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|